Use of herbal medicine related to anxiety and depression in the general population of southeast Iran during the COVID-19 pandemic
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The COVID-19 pandemic has led to increased anxiety/depression and changes in people’s health behaviors. This study aimed to investigate health beliefs regarding using herbal medicine and its associated factors among Iranians. A cross-sectional study on the general population in Birjand (southeast Iran) was conducted using a survey questionnaire (an online platform for creating questionnaires, available at https://porsline.ir/) consisting of demographic characteristics and beliefs toward herbal medicine use, as well as a telehealth and hospital anxiety and depression scale questionnaire to address anxiety and depression disorders. All statistical analysis was done with SPSS software version 18, and a p-value of 0.05 or less was considered significant. The study included 619 participants with a mean age of 36.58±10.74 and a female rate of 61%. The overall use of herbal medicine was 385 (62%), 170 (28%) for prevention, 12 (2%) for treatment, 170 (28%) for relaxation, and 191 (31%) for other reasons. Using herbal medicine for relaxation (p=0.010) and prevention (p=0.02) was significantly associated with less anxiety, while using herbs for the treatment of COVID-19 had an association with no family history of Coronavirus infection (p<0.001). The majority of participants used herbal medicine for different purposes for COVID-19, and this health behavior had a relationship with anxiety/depression and family history of COVID-19. This study's findings would be useful to researchers and policymakers in improving health beliefs and behaviors during the other pandemic in Iran.
Ethics Approval
The study protocol was approved by the Ethical Review Committee of Birjand University of Medical Sciences IR.BUMS.REC.1399.002 on April 10, 2019. The committee assessed the planned project as ethically unobjectionable.How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.